NihBiotechGrantPulse: all 1,000 record reports, page 1 of 5

Every NihBiotechGrantPulse record report, 200 per page, grouped by state. Records 1 to 200: CANCER RESEARCH UNITED KINGDOM: Cancer Grand Challenges: Operations Management Application to MITOTHERAPEUTIX, LLC: cGMP Production, IND-enabling studies, and Phase I Clinical Studies to Test a Novel siRNA drug product for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH). Source: NIH RePORTER (newly awarded projects).

• CANCER RESEARCH UNITED KINGDOM: Cancer Grand Challenges: Operations Management Application
• FRANCIS CRICK INSTITUTE, LTD: BRAIN CONNECTS: X-ray nanotomography for scalable connectomics

Alabama

• SOUTHERN RESEARCH INSTITUTE: Biomedical Research Facility for the Translational Hub for Research, Innovation, Validation, and Excellence (THRIVE)
• TUSKEGEE UNIVERSITY: Carver Genomic Research Center (CGRC)-Building Next Generation Genomic Data Scientist in Rural Alabama
• UNIVERSITY OF ALABAMA AT BIRMINGHAM: 1/2 GLobal trial Of Bromocriptine for PeriPartum CardioMyopathy (GLOBal PPCM)
• UNIVERSITY OF ALABAMA AT BIRMINGHAM: A randomized controlled trial of doxycycline post exposure prophylaxis to prevent incident bacterial STIs among women in the United States
• UNIVERSITY OF ALABAMA AT BIRMINGHAM: Primary Care HEART-NET in the Deep South
• UNIVERSITY OF ALABAMA AT BIRMINGHAM: Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic Transitions
• UNIVERSITY OF SOUTH ALABAMA: Nosocomial pneumonia elicited lung tau impairs learning

Arizona

• ARIZONA STATE UNIVERSITY-TEMPE CAMPUS: Testing Technology-Based Implementation Strategies for a Family-Based Pediatric Health Behavior Intervention in Community-Based Primary Care: A Cluster Randomized Factorial Trial
• CRITICAL PATH INSTITUTE: Critical Path Public Private Partnerships
• MAYO CLINIC ARIZONA: A Phase II Clinical Trial to Test the Efficacy of Rimegepant for Endometriosis-Associated Pain
• MAYO CLINIC ARIZONA: Characterization of Antigen-Specific Immune Response in ALS
• MAYO CLINIC ARIZONA: Mayo Clinic Multiple Myeloma SPORE - Renewal 2025
• ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER: Access for All in ALS (ALL ALS) West Clinical Coordinating Center
• UNIVERSITY OF ARIZONA: 2/2 Partnership for Native American Cancer Prevention
• UNIVERSITY OF ARIZONA: Acquisition of Glacios 2 to Enhance Cryo-EM Access in the Southwest
• UNIVERSITY OF ARIZONA: Neuroendocrine mechanisms of female chronic overlapping pain conditions (COPC)
• UNIVERSITY OF ARIZONA: Retinal neuronal signaling in early diabetes
• UNIVERSITY OF ARIZONA: Transforming Alzheimer's Risk Factor Therapeutics into Precision Combination Therapies to Treat AD
• UNIVERSITY OF ARIZONA: Understanding and Exploiting Loss of Y in Cancer

Arkansas

• ARKANSAS CHILDREN'S HOSPITAL RES INST: Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial
• UNIVERSITY OF ARKANSAS AT FAYETTEVILLE: BRF: Developing Multidisciplinary and Collaborative Research Spaces to Grow Biomedical Research Capacity at the University of Arkansas

California

• AETON THERAPEUTICS, INC.: Human CGAS inhibitors to treat neurodegeneration in Alzheimer's disease
• ARTERY THERAPEUTICS, INC.: Subcutaneous CS6253 9-Month Chronic Toxicology GLP Study in Cynomolgus Monkeys to assess Safety, Tolerability and PK
• AURITEC PHARMACEUTICALS, INC.: Long-acting Injectable Brexpiprazole for Agitation in Alzheimer's Dementia
• BECKMAN RESEARCH INSTITUTE/CITY OF HOPE: 1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
• CALIFORNIA INSTITUTE OF TECHNOLOGY: Neural control of complex human behaviors
• CAPIENDA BIOTECH, LLC: High-throughput kinetic system for small-molecule drug discovery
• CARDIAC RSK3 INHIBITORS, LLC: CRI-103 gene therapy as Investigational New Drug for Dilated Cardiomyopathy
• CATENA BIOSCIENCES, INC.: Advancing Site-Selective Multi-Payload HER2-Targeted Conjugates to Overcome Resistance and Boost Survival in Breast and Gastric Cancers
• CEDARS-SINAI MEDICAL CENTER: Dynamic Predictors of Sudden Cardiac Death
• CEDARS-SINAI MEDICAL CENTER: ERSIAS Phase IIb EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno occlusive Disease Phase IIb Clinical Trial
• CEDARS-SINAI MEDICAL CENTER: Los Angeles Claude D. Pepper Older Americans Independence Center
• CEDARS-SINAI MEDICAL CENTER: Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)
• CEDARS-SINAI MEDICAL CENTER: Viral-mediated immunological niche facilitates lung fibrosis
• CHILDREN'S HOSPITAL OF LOS ANGELES: Targeting obesity to improve survival from childhood acute lymphoblastic leukemia
• CLARIA MEDICAL, INC.: A Multicenter Randomized Controlled Trial of a Safer and Faster Contained Tissue Extraction System for Laparoscopic Hysterectomy
• COG RESEARCH FOUNDATION, LLC: Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base Grant
• COG RESEARCH FOUNDATION, LLC: Pediatric Early Phase Clinical Trials Network (PEP-CTN) Transfer Application
• EMPOWERX, INC.: PEP/PrEP via Pharmacist-Prescribing Implementation (PEPPI)
• GIGAMUNE, INC.: A Novel Lentivector for Enhanced In Vivo Delivery of T Cell Receptors for Cell Therapy for Stage IV Melanoma
• GLYCYX MOR, INC.: A Phase 2 Trial of Axelopran Plus Pembrolizumab for the First-Line Treatment of Recurrent/Metastatic HNSCC That Is PD-L1 Positive (PD-L1CPS >1)
• GLYTR THERAPEUTICS, INC.: Maximizing GlyTR pan-cancer immunotherapy by enhancing target density
• HELLO ROBOT INC: Stretching their Reach: Robotic Support for Older Individuals with Mild Cognitive Impairment and Early Alzheimer's Dementia
• HIDO TECHNOLOGIES, INC.: Commercialization of a Pharmacy-Integrated AI System to Improve Medication Adherence and Reduce Hospitalizations in Dementia Care
• KAISER FOUNDATION RESEARCH INSTITUTE: Coordinated cARe paiN mAnagement Technology ImplementatiON (CARNATION)
• KAISER FOUNDATION RESEARCH INSTITUTE: Defining Successful Care Planning Processes and Outcomes Informed by Patient and Caregiver Perspectives
• KAISER FOUNDATION RESEARCH INSTITUTE: Kaiser Permanente NCI National Community Oncology Research Program, NCORP
• KAISER FOUNDATION RESEARCH INSTITUTE: Using artificially intelligent text messaging technology to improve American Heart Association’s Life’s Simple 7 Health Behaviors: LS7 Bot + Backup
• LAWRENCE LIVERMORE NATIONAL SECURITY, LLC: Technology development for high-resolution biological imaging and structural dynamics
• LEADOPTIK INC.: Optical Precision Targeting for Informed Cancer biopsy (OPTIC)
• LOMA LINDA UNIVERSITY: BRF: LLU Cellular Therapy Research Facility
• MAINSQUARE CO: Engagement and clinical impact of the Teleo virtual therapy platform in clinical settings
• NEONC TECHNOLOGIES HOLDINGS INC.: Developing a Clinically Relevant Radiosensitizer for Temozolomide-resistant Gliomas
• NEURO42, INC.: Portable Intraoperative MRI for Neurosurgery
• OLMEDA BIOSCIENCES LLC: CLIA-LDT Development and Clinical Validation of anAqueous Humor-Based Multiplex Assay for Uveal Melanoma Metastatic Risk Prediction
• OPTICARA LLC: Perfusion assessment of parathyroid glands intra-operatively using a hand heldlaser speckle contrast imaging
• POSIT SCIENCE CORPORATION: Community-based Brain Health Program to Reduce Dementia Risk-BHP
• PUBLIC HEALTH FOUNDATION ENTERPRISES: San Francisco Bay Clinical Trials Unit (CTU)
• RAND CORPORATION: Center to Advance Research Excellence (OPTIC)
• RAND CORPORATION: Data and Methods Core
• REPOXEGEN THERAPEUTICS, INC: Targeting fatty acid metabolic disequilibrium-mediated neuroinflammation asa novel treatment for Alzheimer's disease
• SALK INSTITUTE FOR BIOLOGICAL STUDIES: Solving the Valence Assignment Problem
• SALK INSTITUTE FOR BIOLOGICAL STUDIES: Temporal Context in Brains and Transformers
• SAN DIEGO STATE UNIVERSITY: 1/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership
• SAN DIEGO STATE UNIVERSITY: Study of Latinos- Hearing and Alzheimer's among Latino Older Adults
• SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE: Molecular pathobiology of soluble TREM2 in Alzheimer's disease
• SCINTILLON INSTITUTE FOR PHOTOBIOLOGY: Intersection of Neuro-Immune-Vascular Dynamics in Preclinical NeuroHIV Model
• SCRIPPS RESEARCH INSTITUTE, THE: ADME/FORMULATION Core
• SCRIPPS RESEARCH INSTITUTE, THE: Administrative Core
• SCRIPPS RESEARCH INSTITUTE, THE: Animal and Organoid Model Core
• SCRIPPS RESEARCH INSTITUTE, THE: Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)
• SCRIPPS RESEARCH INSTITUTE, THE: Define the interface between peripheral nerve terminals and metabolic tissues
• SCRIPPS RESEARCH INSTITUTE, THE: Development and validation of antivirals against Flaviviruses
• SCRIPPS RESEARCH INSTITUTE, THE: Development and validation of antivirals against hemorrhagic fever viruses of pandemic concern
• SCRIPPS RESEARCH INSTITUTE, THE: Development of CoV inhibitors against non-enzymatic targets
• SCRIPPS RESEARCH INSTITUTE, THE: HTS Core
• SCRIPPS RESEARCH INSTITUTE, THE: Inhibitors of SARS-CoV-2 proteases
• SCRIPPS RESEARCH INSTITUTE, THE: Medicinal Chemistry Core
• SCRIPPS RESEARCH INSTITUTE, THE: Structural and Modeling Core
• SCRIPPS RESEARCH INSTITUTE, THE: Targeting druggable coronavirus proteins
• SINOPIA BIOSCIENCES, INC.: Development and Validation of Data Standards and Computational Methods for Large Scale Metabolomics Data Analysis for Data Driven Drug Discovery
• SMART BREAST CORPORATION D/B/A SMART BREAST CORP: Commercial-Ready Molecular Breast Imaging (MBI) for Biopsy Guidance
• SMITH-KETTLEWELL EYE RESEARCH INSTITUTE: Maximizing Visual Potential in Age-related Macular Degeneration
• SOUTHERN CALIFORNIA EYE INSTITUTE: RURAL Eye Health Study
• SRI INTERNATIONAL: Targeting Insomnia to Prevent Depression in the Menopause Transition
• STANFORD UNIVERSITY: 1/2 Women's Aneurysm Research: Repair Immediately Or Routine Surveillance: WARRIORS trial
• STANFORD UNIVERSITY: Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
• STANFORD UNIVERSITY: Center for Responsible and Effective AI Technology Enhancement Treatments for PTSD
• STANFORD UNIVERSITY: ClinPGx: The Evolution of PharmGKB and CPIC
• STANFORD UNIVERSITY: CREATE Methods Core
• STANFORD UNIVERSITY: Development of outpatient antiviral cocktails against SARS-CoV-2 and other potential pandemic RNA viruses.
• STANFORD UNIVERSITY: Identification of bacterial derived proteases that inhibit inflammation and pain signaling in the gut
• STANFORD UNIVERSITY: Long COVID Care Resources and Education to Advance Community Health (REACH)
• STANFORD UNIVERSITY: Manipulating and Interrogating Spatial Transcriptomics
• STANFORD UNIVERSITY: Mechanisms of Action of Peripheral Nerve Stimulation for the Treatment of Chronic Neuropathic Pain
• STANFORD UNIVERSITY: Molecular Strategies to Widen the Therapeutic Index of Radiotherapy
• STANFORD UNIVERSITY: Neuronal circuitry of REM sleep pressure
• STANFORD UNIVERSITY: Oral small molecule inhibitors of NSP4-mediated membrane-associated RNA replication of SARS-CoV-2 and other RNA viruses
• STANFORD UNIVERSITY: Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification
• STANFORD UNIVERSITY: Programmable antivirals: Targeting viral RNA secondary structures with LNAs and small molecules
• STANFORD UNIVERSITY: Systems Biology of Tumor-Immune-Stromal Interactions in Metastatic Progression
• STANFORD UNIVERSITY: Targeted Realtime Assessment of Chronic Pain (TRAC-Pain) in Youth
• STANFORD UNIVERSITY: Translation Accelerator Core
• STANFORD UNIVERSITY: Using microfluidics to realize patient-specific anti-cancer immunotherapies
• SWITCH THERAPEUTICS INC.: Liver-Sparing APOE Inhibitor for the Treatment of Alzheimer's Disease in APOE4 Homozygotes
• TEMPO THERAPEUTICS, INC.: MOSAIC II: A Randomized Clinical Study of the MAP Wound Matrix to Reduce Time to Graft-Readiness after Non-Melanoma Skin Cancer Resection
• TRETHERA CORPORATION: Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Crohn's disease
• UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB: Administration Core
• UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB: ALS Efficiently Networking Advanced Beam Line Experiments (ALS-ENABLE)
• UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB: Core 2- Structural Cell Biology (SCB) core
• UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB: Structural Cell Biology of DNA Repair Machine
• UNIVERSITY OF CALIFORNIA AT DAVIS: California Partnership for Personalized Nutrition
• UNIVERSITY OF CALIFORNIA AT DAVIS: Circulating IsomiRs Predict Cause of Ischemic Stroke
• UNIVERSITY OF CALIFORNIA AT DAVIS: Cooperative Agreement to Support the Western Center for Food Safety
• UNIVERSITY OF CALIFORNIA AT DAVIS: Latin American Center for Emerging Infectious Disease Research (LACER)
• UNIVERSITY OF CALIFORNIA AT DAVIS: Molecularly Defined Immunoprobes for Scalable Brain Protein Mapping with Reference Datasets
• UNIVERSITY OF CALIFORNIA AT DAVIS: UC Davis IGA Innovation Center
• UNIVERSITY OF CALIFORNIA AT DAVIS: UC Davis Innovation Center for Honey Bee Therapeutics and Regulatory Science
• UNIVERSITY OF CALIFORNIA BERKELEY: American Asian Centers for Arbovirus Research and Enhanced Surveillance (A2CARES)
• UNIVERSITY OF CALIFORNIA BERKELEY: Close-kin mark-recapture methods to characterize suppression of Aedes aegypti populations resulting from interventions and extreme weather events
• UNIVERSITY OF CALIFORNIA BERKELEY: Integrating AI and Deep Mutational Scanning to Predict the Cancer-Promoting Effect of Shelterin Mutations
• UNIVERSITY OF CALIFORNIA BERKELEY: NexGen 7T MRI scanner for mesoscale brain imaging: Integration and Dissemination
• UNIVERSITY OF CALIFORNIA BERKELEY: Protective immunity following dengue virus natural infections and vaccination
• UNIVERSITY OF CALIFORNIA BERKELEY: SCAN: Standardized, Centralized Alzheimer's and Related Dementias Neuroimaging
• UNIVERSITY OF CALIFORNIA LOS ANGELES: A Pragmatic Trial of Emotional Awareness and Expression Therapy for Veterans with Chronic Pain
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Coherent Raman Scattering (CRS) Microscope
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Dopaminergic Gut-Brain Signaling on Adolescent Reward Learning After Adversity: Toward New, Noninvasive Treatments for Depression and Anxiety
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Evaluating a Multilevel Intervention to Increase Colonoscopic Follow-up after Abnormal Stool-based Colorectal Cancer Screening in a Community Safety-Net Setting
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Lewy-Body Dementia and Environment (LEBEN)
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Quantitative Assessment of Pelvic Floor Muscle Fitness in Myofascial Pelvic Pain
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Regulated, Long-Term Expression of Anti-HIV Antibodies via B Cell Receptor-Targeted Lentiviral Transduction
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Sex related differences in Brain Gut Microbiome Interactions in Irritable Bowel Syndrome
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Sex-specific Mechanisms of Sympathetic Dysregulation in TMD and Comorbid Pain Disorders
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Simulation, modelling, and estimation of direct and indirect genetic architectures and intergenerational dynamics
• UNIVERSITY OF CALIFORNIA LOS ANGELES: Structural biology of 7SK RNP and its interaction with HIV-1 Tat
• UNIVERSITY OF CALIFORNIA RIVERSIDE: 2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
• UNIVERSITY OF CALIFORNIA SANTA BARBARA: RaceCAR-M immunotherapy for cancer and beyond
• UNIVERSITY OF CALIFORNIA SANTA CRUZ: Center for Human Genome Reference Diversity
• UNIVERSITY OF CALIFORNIA-IRVINE: Integration and functionality of retinal organoid transplants
• UNIVERSITY OF CALIFORNIA-IRVINE: Precision genome editing in vivo to treat retinal diseases
• UNIVERSITY OF CALIFORNIA, SAN DIEGO: 2/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership
• UNIVERSITY OF CALIFORNIA, SAN DIEGO: ABCD-USA Consortium: Coordinating Center
• UNIVERSITY OF CALIFORNIA, SAN DIEGO: Administrative Core
• UNIVERSITY OF CALIFORNIA, SAN DIEGO: Cell-free RNA signature for Diagnosis and Personalized Therapeutics in Children with Kawasaki Disease
• UNIVERSITY OF CALIFORNIA, SAN DIEGO: Heterogeneity of subtle cognitive decline phenotypes in community-dwelling older adults
• UNIVERSITY OF CALIFORNIA, SAN DIEGO: Pathophysiologic roles of alpha-synuclein at the synapse
• UNIVERSITY OF CALIFORNIA, SAN DIEGO: The Connectome of Primate Motor Systems for Hand Control
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Bay Area Cancer Target Discovery and Development
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Contraceptive use patterns in the peripartum time period
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: CTSA K12 Program at UCSF
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Defining broadly neutralizing antibody pharmacokinetics-pharmacodynamics in curative HIV trials
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: I CAN DO Surgical ACP (Improving Completion, Accuracy, and Dissemination Of Surgical Advanced Care Planning) Trial
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Identifying transcriptomic and exposomic factors that explain sex-specific trajectories AD/ADRD using integrative computational approaches
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: In vitro virology core
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Inhibiting Viral Macrodomains Using Structure-Based Design
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Medicinal chemistry core
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Molecular determinants and consequences of disease-specific tau conformers in neurons and glia
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Proteomics core
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: QCRG Pandemic Response Program
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Role of Coordinated Multi-Area Reactivations During Transitions Between Automatic and Flexible Behaviors
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Simulating Ancestrally Unbiased Tumor Evolution To Interrogate Drug Resistance
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Spatial multiomic mapping of gene function with CRISPRoff
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Targeting Viral RNA Using a Sequence Programmable Small Molecule-Oligonucleotide Conjugate
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: The Cancer Cell Map Initiative v2.0
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: UCSF Clinical and Translational Science Institute
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: UCSF REACH Multimodal Modeling in Chronic Low Back Pain
• UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Virtual Incentivized Viral suppression Intervention with Direct observation (VIVID) for People with HIV
• UNIVERSITY OF SOUTHERN CALIFORNIA: 3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center
• UNIVERSITY OF SOUTHERN CALIFORNIA: Artificial Intelligence-Assisted Teleophthalmology for Glaucoma Screening: A Randomized Controlled Trial (GATES)
• UNIVERSITY OF SOUTHERN CALIFORNIA: NovaSeq X Plus Sequencing System
• UNIVERSITY OF SOUTHERN CALIFORNIA: Reliable AI for Medical Image Reconstruction
• UNIVERSITY OF SOUTHERN CALIFORNIA: USC PE-GCS: Optimizing Engagement of Hispanic Colorectal Cancer Patients in Cancer Genomic Characterization Studies
• VESICA CORPORATION: Artificial Intelligence Enhanced Detection and Monitoring of Bladder Cancer
• VIVID VISION, INC.: Use of a virtual reality headset to test the untestable patients with glaucoma
• XR NAVIGATION INC.: Developing and Evaluating Visual, Auditory, and Tactile and Text Digital Thematic Map Viewer to Provide Blind and Low Vision Individuals Full Access to Thematic Maps for the First Time
• YOURCHOICE THERAPEUTICS, INC.: Tablet development and relative bioavailability study in men for ongoing clinical development of YCT-529 as an oral non-hormonal male contraceptive

Colorado

• ALLANDER BIOTECHNOLOGIES, INC.: cGMP manufacturing the clinical batch of oral gel drug for treating oral mucositis in cancer patients
• ALLANDER BIOTECHNOLOGIES, INC.: First-in-human clinical trial of proprietary oral gel to treat radiation-induced oral mucositis in cancer patients
• COLORADO STATE UNIVERSITY: Center for Bat One Health Investigations, Research, and Outbreak Response (CHIRO)
• COLORADO STATE UNIVERSITY: Examining Gut Microbiome as a Determinant of Blueberry Polyphenol Bioavailability to Optimize Dose and Phytochemical Standardization for Functional Effects in Humans
• COMMONSPIRIT HEALTH RESEARCH INSTITUTE: CIRI Oncology Research Alliance
• NATIONAL JEWISH HEALTH: 1/2 Efficacy and Safety of Obinutuzumab in Connective Tissue Disease-Related Interstitial Lung Disease
• NATIONAL JEWISH HEALTH: 1/2 Precision Tapering of Biologic Therapy in Asthma: Identifying Predictors of Successful Dupilumab Interval Extension
• NATIONAL JEWISH HEALTH: Cellular, molecular and epigenetic mechanisms of allergic diseases
• NUMIERA THERAPEUTICS INC: Targeting Fatty Acid Oxidation with Etomoxir for the Treatment of Recurrent Glioblastoma
• UNIVERSITY OF COLORADO DENVER: Brain capillary endothelial cell energetics and neurovascular uncoupling in dementia
• UNIVERSITY OF COLORADO DENVER: Lumick's C-trap, optical trapping system
• UNIVERSITY OF COLORADO DENVER: Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US Project
• UNIVERSITY OF COLORADO DENVER: Mechanisms of meningeal barrier development and disruption
• UNIVERSITY OF COLORADO DENVER: Mechanisms Regulating Lung Injury and Early Lung Fibrosis
• UNIVERSITY OF COLORADO DENVER: Multi-Disciplinary Research Training in Respiratory Disease
• UNIVERSITY OF COLORADO DENVER: Network for Advancing Sex Chromosome Aneuploidy Research Readiness (NASCARR)
• UNIVERSITY OF COLORADO DENVER: Novel Statewide Response to Post-COVID Care Delivery
• UNIVERSITY OF COLORADO DENVER: Optimizing Acute Care Rehabilitation for Critically Ill Adults

Connecticut

• CELLSBIN, INC.: Detection and Isolation of Circulating Myeloma Cells: Toward a Minimally-Invasive CLIA-Certified Diagnostic for Multiple Myeloma
• MITOTHERAPEUTIX, LLC: cGMP Production, IND-enabling studies, and Phase I Clinical Studies to Test a Novel siRNA drug product for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Browse NihBiotechGrantPulse by category and location · Search and filter NihBiotechGrantPulse